IP Verse

Cafa Therapeutics competitive analysis

Loading summary...

Latest patents of Cafa Therapeutics opposed by its competitors

Explore Cafa Therapeutics's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 23, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP3445407
Dec 14, 2022Compositions And Methods Of Cellular Immunotherapy2
EP3170842
Sep 4, 2019Immunologic Effector Cell Of Targeted Cld18A2, And Preparation Method And Use Thereof1

Latest publications and patents of Cafa Therapeutics New

Explore the latest publications and patents granted to Cafa Therapeutics, showcasing their recent innovations and technological advancements.

Last updated on: Oct 18, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Cafa Therapeutics

EP3445407
Dec 14, 2022Compositions And Methods Of Cellular ImmunotherapyGranted And Under Opposition
EP3170842
Sep 4, 2019Immunologic Effector Cell Of Targeted Cld18A2, And Preparation Method And Use ThereofRevoked

Latest PTAB cases involving Cafa Therapeutics

Discover the latest PTAB cases involving Cafa Therapeutics, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Cafa Therapeutics with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 23, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
CAFA THERAPEUTICS - 3 - -
BIONTECH CELL & GENE THERAPIES1 - - -
MURGITROYD19 - - -
SOTIO BIOTECH1 - - -